rs386833682
Variant summary
Our verdict is Pathogenic. The variant received 14 ACMG points: 14P and 0B. PM2PP3_StrongPP5_Very_Strong
The NM_000481.4(AMT):c.434A>T(p.Asn145Ile) variant causes a missense change involving the alteration of a conserved nucleotide. The variant allele was found at a frequency of 0.00000274 in 1,461,888 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Likely pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. N145S) has been classified as Uncertain significance.
Frequency
Consequence
NM_000481.4 missense
Scores
Clinical Significance
Conservation
Publications
- glycine encephalopathyInheritance: AR Classification: DEFINITIVE, STRONG Submitted by: ClinGen, Labcorp Genetics (formerly Invitae), Myriad Women’s Health
- glycine encephalopathy 2Inheritance: AR Classification: DEFINITIVE Submitted by: G2P
- infantile glycine encephalopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- neonatal glycine encephalopathyInheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet
- atypical glycine encephalopathyInheritance: Unknown Classification: SUPPORTIVE Submitted by: Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Pathogenic. The variant received 14 ACMG points.
Transcripts
RefSeq
| Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
|---|---|---|---|---|---|---|---|---|
| AMT | NM_000481.4 | c.434A>T | p.Asn145Ile | missense_variant | Exon 4 of 9 | ENST00000273588.9 | NP_000472.2 |
Ensembl
Frequencies
GnomAD3 genomes Cov.: 32
GnomAD2 exomes AF: 0.00000398 AC: 1AN: 251492 AF XY: 0.00000736 show subpopulations
GnomAD4 exome AF: 0.00000274 AC: 4AN: 1461888Hom.: 0 Cov.: 31 AF XY: 0.00000550 AC XY: 4AN XY: 727246 show subpopulations
GnomAD4 genome Cov.: 32
ClinVar
Submissions by phenotype
Glycine encephalopathy Pathogenic:2
Variant summary: AMT c.434A>T (p.Asn145Ile) results in a non-conservative amino acid change located in the aminomethyltransferase, folate-binding domain (IPR006222) of the encoded protein sequence. Five of five in-silico tools predict a damaging effect of the variant on protein function. The variant allele was found at a frequency of 4e-06 in 251492 control chromosomes. c.434A>T has been reported in the literature in in the homozygous and compound heterozygous states in multiple individuals affected with Glycine Encephalopathy (Non-Ketotic Hyperglycinemia) (e.g. Toone_2001, Bayrak_2021, Coughlin_2017). These data indicate that the variant is very likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 33791923, 27362913, 11286506, 31395954). ClinVar contains an entry for this variant (Variation ID: 56231). Based on the evidence outlined above, the variant was classified as likely pathogenic.
Glycine encephalopathy 2 Pathogenic:2
NM_000481.3(AMT):c.434A>T(N145I) is a missense variant classified as likely pathogenic in the context of glycine encephalopathy, AMT-related. N145I has been observed in cases with relevant disease (PMID: 11286506, 27362913, 31395954, 33791923). Relevant functional assessments of this variant are not available in the literature. N145I has been observed in referenced population frequency databases. In summary, NM_000481.3(AMT):c.434A>T(N145I) is a missense variant that has been observed more frequently in cases with the relevant disease than in healthy populations. Please note: this variant was assessed in the context of healthy population screening.
Glycine encephalopathy 1 Pathogenic:1
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at